For its 6th edition, Audacious will celebrate the strength of collaborations, embodied by the work of Susan McPeak and Anne Marinier, who personify the mobilizing power of a concerted effort in the fight against cancer.
The former is co-founder of the McPeak-Sirois Group for Clinical Research in Breast Cancer, bringing together many players in the field. The latter is a Principal Investigator at the IRIC and director of the country’s largest medicinal chemistry core facility in a university setting.
The event will be co-chaired by:
- Madeleine Féquière, Corporate Credit Chief, Domtar
- Ève Laurier, General Manager, Edelman Montréal
- Louise Roy, Chancellor Emerita, Université de Montréal and Chair of the Board, CIRANO
Wednesday, May 29, 2019, at 6:00 PM
Salle des pas perdus, Gare Windsor
1160 Avenue des Canadiens-de-Montréal
To sponsor the event, please refer to the Sponsorship Plan and fill the confirmation form. Please note that it is possible for a company to make a major three-year sponsorship commitment or to develop a personalized sponsorship.
For more information concerning the 6th edition of Audacious:
514-343-6141 | email@example.com
Charitable registration number: 10816 0995 RR0001
Vanquishing cancer differently
Since 2014, the IRIC has been hosting Audacious, an annual fundraising event showcasing the IRIC’s activities to the members of the business community in attendance and supporting promising discoveries in the fight against cancer. Led by devoted and generous Co-chairs and a Financing Committee, Audacious brings together 450 guests every year from the business sector, partners and Investigators.
The IRIC uses this opportunity to underline its scientific progress and to honour the people whose commitment make a difference in the fight against cancer. Thus, year after year, the IRIC highlights the exceptional work of its Investigators, such as Dr. Guy Sauvageau or Dr. Claude Perreault, or the tremendous generosity of its donors, such as Mrs. and Mr. Marcelle and Jean Coutu, Mr. Serge Godin or Mr. Pierre Pomerleau.
Since its first edition, Audacious has raised $4,865,000 to sustain cancer research efforts. These sums notably enabled the Institute to recruit Matthew Smith, Principal Investigator of the Cancer Signalling and Structural Biology Research Unit, to award approximately 50 scholarships to the next generation of Investigators, to fund the innovative chemolibrary project and to acquire a great deal of equipment, including a plate reader and a mass spectrometer.